ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACOR Acorda Therapeutics Inc

11.91
0.00 (0.00%)
Pre Market
Last Updated: 03:05:07
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 10.35
Ask Price 19.35
News -
Day High

Low
8.978

52 Week Range

High
24.196

Day Low
Share Name Share Symbol Market Stock Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 11.91 03:05:07
Open Price Low Price High Price Close Price Previous Close
11.91
Trades Shares Traded Average Volume 52 Week Range
0 0 - 8.978 - 24.196
Last Trade Type Quantity Price Currency
- 0 US$ 11.91 USD

Acorda Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.79M 1.24M - 131.12M -65.92M -53.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acorda Therapeutics News

Date Time Source News Article
3/25/202415:01Business WireAcorda Fourth Quarter/Year End 2023 Update:..
1/11/202407:33Edgar (US Regulatory)Form 8-K - Current report
1/11/202407:01Business WireAcorda Therapeutics to Regain Global Commercialization..
12/01/202315:30Edgar (US Regulatory)Form 8-K - Current report
11/13/202315:16Edgar (US Regulatory)Form 8-K - Current report
11/13/202315:01Business WireAcorda Therapeutics Reports Third Quarter 2023 Financial..
11/06/202315:01Business WireAcorda Third Quarter 2023 Update: Webcast/Conference Call..
11/06/202307:00Business WireAcorda Therapeutics Announces Biopas Laboratories Submission..
8/08/202315:12Edgar (US Regulatory)Form 8-K - Current report
8/08/202315:01Business WireAcorda Therapeutics Reports Second Quarter 2023 Financial..
8/02/202307:00Business WireAcorda Therapeutics Announces Launch of New INBRIJA®..
8/01/202307:00Business WireAcorda Second Quarter 2023 Update: Webcast/Conference Call..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACOR Message Board. Create One! See More Posts on ACOR Message Board See More Message Board Posts

Historical ACOR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.5013.1811.81112.083,106-0.59-4.72%
1 Month14.0914.7511.81112.874,525-2.18-15.47%
3 Months14.4518.0011.81114.673,786-2.54-17.58%
6 Months14.78518.009.1012.694,963-2.88-19.45%
1 Year10.81824.1968.97816.86215,7951.0910.09%
3 Years98.40127.205.22227.86703,823-86.49-87.90%
5 Years1,568.401,623.605.222155.781,346,309-1,556.49-99.24%

Acorda Therapeutics Description

Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Your Recent History

Delayed Upgrade Clock